Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy
Open Access
- 6 September 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (9) , e0203051
Abstract
The aim of this study was to validate a molecular classification of colorectal cancer (CRC) based on microsatellite instability (MSI), CpG island methylator phenotype (CIMP) status, BRAF, and KRAS and investigate each subtype’s response to chemotherapy. This retrospective observational study included a population-based cohort of 878 CRC patients. We classified tumours into five different subtypes based on BRAF and KRAS mutation, CIMP status, and MSI. Patients with advanced stage II (T4N0M0) and stage III tumours received 5-fluoruracil (5-FU)-based chemotherapy or no adjuvant treatment based on clinical criteria. The main outcome was disease-free survival (DFS). Patients with the combination of microsatellite stable (MSS) tumours, BRAF mutation and CIMP positive exhibited the worst prognosis in univariate (log rank PKRAS mutation and CIMP negative (log rank P = 0.003) as well as in patients with MSS tumours plus BRAF and KRAS wild-type and CIMP negative (log-rank PKRAS and BRAF mutation. Patients with traditional chromosomally unstable tumours obtained the best benefit from adjuvant 5-FU-based chemotherapy.Keywords
Funding Information
- Instituto de Salud Carlos III (PI08/0726, INT-09/208, PI11/2630, INT-12-078, INT13-196, PI14/01386)
- FISABIO-ISABIAL (UGP-13-221, UGP-14-265)
- Fundación Científica Asociación Española Contra el Cáncer (GCB13131592CAST)
- Instituto de Salud Carlos III (FI12/00233)
- VAL I+D (ACIF/2016/002)
- ISABIAL (UGP-16-138)
- Asociación Española de Gastroenterología (Beca Gonzalo Miño 2014, Tamarite 2015, Grupo Endoscopia 2016)
This publication has 32 references indexed in Scilit:
- Erratum: Consensus molecular subtypes and the evolution of precision medicine in colorectal cancerNature Reviews Cancer, 2017
- Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal CancerClinical Cancer Research, 2016
- Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia PathwayArchives of Pathology & Laboratory Medicine, 2016
- Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysisAnnals of Oncology, 2014
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Prevalence and Characteristics of MUTYH-Associated Polyposis in Patients with Multiple Adenomatous and Serrated PolypsClinical Cancer Research, 2014
- Susceptibility Genetic Variants Associated With Colorectal Cancer Risk Correlate With Cancer PhenotypeGastroenterology, 2010
- The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patientsAnnals of Oncology, 2010
- CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancerGut, 2008
- A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.1998